Chemomab Therapeutics News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

25.07.24	Chemomab Therapeutics Reveals Data From Mid-Stage Study For Liver Disease Candidate, Stock Plunges On Capital Raise (Benzinga)
25.07.24	Chemomab Reports Positive Results For Phase 2 Trial Of CM-101 (RTTNews)
20.02.24	What's Going On With Fibro-Inflammatory Disease Focused Chemomab Therapeutics On Tuesday? (Benzinga)
15.11.23	Chemomab Reports Fast Track Designation For CM-101 - Quick Facts (RTTNews)
21.06.23	Chemomab Reports Positive Results From Secondary Analyses Of CM-101 Phase 2a Liver Fibrosis Trial (RTTNews)
05.06.23	Hemomab Therapeutics Reappoints Adi Mor As CEO; Sigal Fattal Reassumes Role Of CFO (RTTNews)
21.02.23	Chemomab : FDA Clears IND Application For Phase 2 Trial Of CM-101 In Systemic Sclerosis; Stock Up (RTTNews)
04.01.23	Pre-market Movers: DDI, VERA, CHEK, AMV, ENVX… (RTTNews)
03.01.23	Chemomab Jumps 35% After Reporting NASH Trial Data (RTTNews)
22.04.22	Pre-market Movers: SCYX, DAIO, OMEX, CRSR, GPS… (RTTNews)
20.12.21	Chemomab to Participate in LifeSci Partners Annual Corporate Access Event and H.C. Wainwright BioConnect 2022 Healthcare Conference (PR Newswire)
03.12.21	Chemomab Therapeutics Names David M. Weiner, MD as Interim Chief Medical Officer (PR Newswire)
21.10.21	Pre-market Movers: DWAC, DUO, TSC, IHT, NXTP… (RTTNews)
02.09.21	Chemomab Therapeutics Names Dale Pfost CEO, Chairman-designate - Quick Facts (RTTNews)
13.08.21	Chemomab Therapeutics Announces Second Quarter 2021 Financial Results and Provides a Business Update (PR Newswire)
23.06.21	Chemomab Therapeutics and AGC Biologics Expand Partnership to Manufacture CM-101 for Phase II/III (PR Newswire)
10.06.21	Chemomab Announces Poster Presentation at the International Liver Congress 2021 (EASL) (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Givaudan	4’040.00	1.71 %	K V
Geberit	547.80	1.59 %	K V
Part Grp Hldg	1’297.00	1.49 %	K V
ABB	51.94	1.29 %	K V
Swiss Life Hldg	691.80	1.26 %	K V
Zurich Insur Gr	548.00	-0.18 %	K V
Kuehne+Nagel Int	210.90	-0.33 %	K V
Swiss Re	128.20	-0.66 %	K V
Sonova Hldg	293.00	-0.85 %	K V
Novartis	87.94	-0.92 %	K V